Wylone 4 Tablet contains Methylprednisolone 4 mg, a synthetic glucocorticoid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the management of various inflammatory and autoimmune conditions, including allergic reactions, asthma, rheumatoid arthritis, lupus erythematosus, and certain dermatological disorders. Methylprednisolone works by modulating the immune response and inhibiting the release of inflammatory mediators, thereby reducing tissue inflammation and edema. This medication is also utilized in the treatment of adrenal insufficiency and as an adjunct in certain hematologic and neoplastic diseases. Wylone 4 Tablet should be administered under medical supervision, with dosage tailored to the specific condition and patient response. Common side effects may include gastrointestinal disturbances, increased susceptibility to infections, mood changes, and hyperglycemia. Long-term use requires monitoring for potential adverse effects such as osteoporosis, cataracts, and adrenal suppression. Caution is advised in patients with diabetes, hypertension, peptic ulcer disease, or systemic infections. Abrupt discontinuation should be avoided to prevent withdrawal symptoms; tapering of the dose is recommended when discontinuing therapy. Wylone 4 Tablet is contraindicated in patients with systemic fungal infections and known hypersensitivity to corticosteroids. Always consult a healthcare professional before initiating treatment.